Feb 1, 2025
Being selected for Editor’s Choice underscores the originality and scientific significance of this research within the field of headache medicine.
The International Headache Society has recognized the paper titled “Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice,” authored by E. Zorrilla and colleagues, as the Cephalalgia Editor’s Choice for February 2025.
The study investigates the effects of combined CBD and THC on migraine-like symptoms in preclinical models, presenting innovative approaches in cannabinoid-based migraine research.
Being selected for Editor’s Choice underscores the originality and scientific significance of this research within the field of headache medicine.
The article can be accessed in Cephalalgia, Volume 45, Issue 2, 2025, with DOI: 10.1177/03331024251314487.